Rolling circle amplification method and DNA nanosphere preparation method

By performing rolling circle amplification under isothermal conditions, the reagent addition steps and equipment requirements are simplified, solving the problems of high equipment dependence and large batch-to-batch variability in existing technologies, and realizing efficient large-scale production of DNA nanospheres.

CN118910229APending Publication Date: 2024-11-08ZHUHAI GENDOW BIOTECHNOLOGY CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202410969948.1
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-18
Publication Date
2024-11-08

AI Technical Summary

Technical Problem

Existing rolling circle amplification methods require multiple steps and rely on PCR thermal cyclers, resulting in high equipment requirements, large batch-to-batch variations, low efficiency, and difficulty in achieving automation and large-scale production.

Method used

Rolling circle amplification is performed under isothermal conditions. Double-stranded DNA is denatured by a denaturing agent, and circular fragments, ligases, and polymerases are introduced into the same reaction system. This simplifies reagent addition steps, avoids complex temperature control equipment, and uses thermostable enzymes for amplification at high temperatures.

Benefits of technology

The experimental procedures were simplified, equipment requirements were reduced, reaction efficiency was improved, batch-to-batch variations were avoided, and large-scale fabrication of DNA nanospheres was achieved.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118910229A_ABST
    Figure CN118910229A_ABST
Patent Text Reader

Abstract

The invention relates to a rolling circle amplification method and a preparation method of DNA nanospheres. The rolling circle amplification method is carried out under a constant temperature condition, and comprises the following steps: mixing double-stranded DNA with a denaturant, then carrying out denaturation to prepare a denaturation system, and phosphorylating the 5'end of at least one strand in the double-stranded DNA; after DNA double-strand denaturation, reagents including a cyclization fragment, ligase and polymerase are introduced into a denaturation system at the same time, and a reaction system is prepared; in a reaction system, the two ends of the denatured single-stranded DNA are paired with a cyclization sequence at the same time, ligase enables the two ends of the single-stranded DNA to be connected to form a single-stranded DNA ring, and polymerase performs rolling circle amplification by taking a cyclization fragment as a primer and the single-stranded DNA ring as a template.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present application belongs to the technical field of high-throughput sequencing, and specifically relates to a rolling circle amplification method and a preparation method of DNA nanospheres. Background Art

[0002] Rolling circle amplification (RCA) is a common library amplification method in the fields of next-generation sequencing and in situ sequencing. Using circular DNA as the starting template, amplification is performed in an isothermal environment under the action of a polymerase with a chain displacement function. Its product is a linear, continuous sequence that is reverse complementary to the circular DNA sequence. The morphology of its product can be regulated to a certain extent by the fixed sequence on the circular DNA. Compared with PCR, the amplification multiple of rolling circle amplification is less, but it does not require frequent temperature changes, and can avoid the accumulation of errors caused by PCR. Therefore, in certain circumstances, it has more advantages than PCR.

[0003] Compared with other amplifications, the most important thing about rolling circle amplification is the production of circular DNA. This step is extremely cumbersome. Taking the double-stranded DNA produced by conventional PCR as an example, it first needs to be single-stranded, that is, one chain is selected for digestion, and the 5' end of the remaining single chain is phosphorylated. After obtaining the single-stranded state and the 5'-phosphorylated DNA single-stranded template, the 3' end of the DNA single-stranded template is guided to the 5' end through a circular primer that can hybridize with the DNA single strand at the same time, and the 3' hydroxyl group of the 3' end base and the 5' phosphate group of the 5' end base are in adjacent positions. Then, under the action of DNA ligase, the 3' end of the DNA single-stranded template is connected to the 5' end to form a complete circle. After that, the product needs to be purified and digested to remove the uncircularized product and retain only the circular DNA. This series of steps usually requires manual operation, and it is difficult to achieve automation even with professional kits. This is particularly evident in BGI's early gene sequencer products. In the preparation for sequencing, the step of circularizing the library after interruption or PCR is long, inefficient, and requires a large amount of initial library input. In subsequent developments, some companies, including BGI, have launched products or patents for one-step construction of DNA nanoballs, integrating the circularization and rolling circle steps to reduce the library input. This allows users to start with a 5' phosphorylated double-stranded library, operate the double-stranded library through a PCR thermal cycler, and obtain DNA nanoballs that can be sequenced.

[0004] The various one-step methods disclosed in the prior art also require multiple steps and require the use of a PCR thermal cycler to complete the production of DNA nanospheres. For example, the kit for constructing DNA nanospheres using the one-step method disclosed in the prior art is as follows:

[0005] The user must first dilute the double-stranded library and mix it with reagent Mix1, then use a PCR thermal cycler to raise the temperature of the mixture to denaturation, then cool it down to renaturation, then add reagent Mix2, set a certain temperature for a period of time, and then add the terminator to terminate the reaction. Its main disadvantages are as follows:

[0006] 1. Multiple reagent addition steps require repeated opening and closing of the PCR thermal cycler and sample container, which is very likely to cause exogenous contamination.

[0007] 2. These steps require multiple, precisely controlled temperatures, making a PCR thermal cycler a necessity and raising the barrier to use.

[0008] 3. At the same time, in order to accurately control the temperature, the PCR thermal cycler also has a limit on the capacity of the reaction container, which is mostly 200μl. This means that when making a large number of DNA nanospheres, it is necessary to use multiple PCR tubes. At the same time, when adding reagents later, they also need to be added to each PCR tube separately, which can easily lead to inconsistent results in each PCR product.

[0009] 4. Since the temperature needs to be raised and lowered multiple times to be precisely controlled at multiple temperature points, and reagents need to be added to multiple PCR tubes multiple times, the actual DNA nanosphere production time is much longer than the incubation time set on the PCR thermal cycler.

[0010] Similar situations also exist in mature commercial one-step reagents, such as the MGI DNBSEQ-E25RS high-throughput sequencing reagent set. Their general technical principles and process settings are as follows: Figure 1-Figure 2 shown. Summary of the invention

[0011] Based on this, it is necessary to provide a method of rolling circle amplification in one embodiment of the present application, which can be used to prepare DNA nanospheres.

[0012] The technical solutions include the following:

[0013] A method for rolling circle amplification, which is carried out under constant temperature conditions and comprises the following steps:

[0014] The double-stranded DNA is mixed with a denaturant and then denatured to prepare a denaturation system, wherein the 5' end of at least one strand of the double-stranded DNA is phosphorylated;

[0015] After the double-stranded DNA is denatured, reagents including a circular fragment, a ligase and a polymerase are simultaneously introduced into the denaturation system to prepare a reaction system; in the reaction system, both ends of the denatured single-stranded DNA are simultaneously paired with the circular fragment, the ligase connects the two ends of the single-stranded DNA to form a single-stranded DNA ring, and the polymerase performs rolling circle amplification using the circular fragment as a primer and the single-stranded DNA ring as a template.

[0016] In one embodiment, the total volume of the introduced reagents including the circularized fragment, the ligase and the polymerase is 1-1000 times the volume of the denaturation system.

[0017] Optionally, the total volume of the reagents introduced including the circularized fragment, the ligase and the polymerase is 1-500 times the volume of the denaturation system; optionally, the total volume of the reagents introduced including the circularized fragment, the ligase and the polymerase is 80-150 times the volume of the denaturation system.

[0018] Optionally, the total volume of the introduced reagents including the circularized fragment, the ligase and the polymerase is 15-20 times the volume of the denaturation system.

[0019] In one embodiment, the denaturant includes one or more of a strong base and formamide; optionally, the denaturant is a strong base; further optionally, the strong base includes NaOH and KOH; optionally, the concentration of the strong base in the denaturation system is at the mol / L level.

[0020] In one embodiment, the constant temperature condition is 40°C-80°C.

[0021] In one embodiment, the ligase is a thermostable ligase, the polymerase is a thermostable polymerase, and the suitable reaction temperature of the ligase and the polymerase is in the range of 20°C-100°C.

[0022] In one embodiment, the reaction time of the ligase and the polymerase is 10 min-100 min; optionally, the reaction time of the ligase and the polymerase is 10 min-15 min.

[0023] In one embodiment, one or more of ATP, salt and neutralizer are also introduced into the reaction system;

[0024] In one embodiment, the salt includes one or more of Tris-HCl, tetramethylammonium chloride and Mg(CH3COO)2;

[0025] In one embodiment, the neutralizing agent comprises an acid.

[0026] In one embodiment, the volume of the reaction system is 1 μL-100 mL; optionally, the volume of the reaction system is 80 μL-10 mL.

[0027] A method for preparing a DNA nanoball comprises preparing the DNA nanoball by the method described above; optionally, the preparation method further comprises terminating an amplification reaction with a terminator to obtain the DNA nanoball.

[0028] A sequencing method comprises the following steps:

[0029] Prepare DNA nanospheres according to the rolling circle amplification method; and

[0030] The DNA nanoballs are sequenced to obtain sequencing results.

[0031] Compared with the prior art, this application has the following beneficial effects:

[0032] The present application provides a method for rapid rolling circle amplification under mild constant temperature. The starting material of the reaction of DNA nanoballs in this method is a double-stranded DNA with at least one 5' end phosphorylated, and is no longer a single-stranded DNA ring, which eliminates the cumbersome cyclization and purification process in the production of DNA nanoballs; at the same time, the method is carried out at a constant temperature close to room temperature, and only a simple constant temperature device is required, and no expensive temperature control equipment is required to participate in the temperature rise and fall; at the same time, the reagent addition method of the method is simplified, and no additional renaturing agent is required, and the number of times the reagent is added to the system during the reaction is reduced; at the same time, the method avoids the limitation of PCR tubes, and can be used in a single reaction container. The production of large-volume DNA nanoballs avoids the batch differences generated in the production of large quantities of DNBs. In summary, this method simplifies the experimental steps, reduces the requirements for experimental equipment, increases the maximum reaction scale limit, improves the reaction efficiency, and reduces the interference of operations during the reaction. BRIEF DESCRIPTION OF THE DRAWINGS

[0033] Figure 1 The technical principle of the prior art;

[0034] Figure 2 Process setup for existing technologies;

[0035] Figure 3 The technical principle of this application method;

[0036] Figure 4 This is the process setting for this application method. DETAILED DESCRIPTION

[0037] In order to make the above-mentioned purposes, features and advantages of the present application more obvious and easy to understand, the specific implementation methods of the present application are described in detail below. In the following description, many specific details are set forth to facilitate a full understanding of the present application. However, the present application can be implemented in many other ways different from those described herein, and those skilled in the art can make similar improvements without violating the connotation of the present application, so the present application is not limited by the specific embodiments disclosed below.

[0038] Unless otherwise defined, all technical and scientific terms used herein have the same meaning as those commonly understood by those skilled in the art to which this application belongs. The terms used herein in the specification of this application are only for the purpose of describing specific embodiments and are not intended to limit this application.

[0039] Herein, the optional scope of "and / or", "or / and", and "and / or" includes any one of two or more relevant listed items, and also includes any and all combinations of the relevant listed items, wherein said any and all combinations include any two relevant listed items, any more relevant listed items, or a combination of all relevant listed items.

[0040] In this application, when it comes to numerical ranges, unless otherwise specified, the above numerical ranges are deemed to be continuous and include the minimum and maximum values ​​of the range, as well as each value between such minimum and maximum values. Further, when a range refers to an integer, each integer between the minimum and maximum values ​​of the range is included. In addition, when multiple ranges are provided to describe features or characteristics, the ranges can be merged. In other words, unless otherwise specified, all ranges disclosed herein should be understood to include any and all subranges included therein.

[0041] The temperature parameters in this application, unless otherwise specified, allow both constant temperature treatment and treatment within a certain temperature range. The constant temperature treatment allows the temperature to fluctuate within the accuracy range controlled by the instrument, such as within the range of ±2°C, ±1°C, ±0.5°C, ±0.4°C, ±0.3°C, ±0.2°C, and ±0.1°C.

[0042] The present application designs a method for rapidly performing rolling circle amplification and preparing DNA nanoballs under mild and constant temperature. At a given temperature, double-stranded DNA is denatured by a denaturant; while keeping the temperature constant, a circularization sequence, a ligase, a polymerase and other reaction components are introduced into the reaction system, and the denaturant is neutralized at the same time; after the denaturant is neutralized, the two ends of the single-stranded DNA are paired with the circularization primer in the system; after pairing, the ligase in the system immediately connects the two ends of the single-stranded DNA; after connection, the polymerase in the system immediately uses the single-stranded DNA ring as a template for a rolling circle amplification reaction to obtain an amplified product. This method optimizes the systems of denaturation, renaturation, circularization and rolling circle amplification respectively, and innovatively adjusts the processes of denaturation, renaturation, circularization and rolling circle amplification at the same reaction temperature, and adapts renaturation, circularization and rolling circle amplification to the same reaction system. This series of innovations gives the present application the following advantages:

[0043] 1. The rolling circle amplification and DNA nanosphere preparation process only requires the addition of additional reagents once, can be performed at a constant temperature in the same reactor, and is not limited to a PCR thermal cycler.

[0044] 2. Use denaturants to denature the library (DNA double strands with 5' end phosphorylated), avoiding unnecessary heating denaturation steps. At the same time, the addition of large volumes of subsequent reagents containing enzymes and buffers can neutralize the denaturants in the small volume denaturation system. No additional renaturation agent is needed to renature.

[0045] 3. The reaction is carried out at a mild constant temperature. The production of rolling circle amplification and DNA nanospheres can get rid of the expensive PCR thermal cycler and use a constant temperature water bath with general precision temperature control.

[0046] 4. The reaction container for making DNA nanospheres is no longer limited to the volume of PCR tubes. Larger containers can be used to synthesize larger volumes of DNA nanospheres.

[0047] 5. The production of large-volume DNA nanospheres no longer requires separate production in multiple PCR tubes followed by mixing, and the uniformity of the product is better guaranteed.

[0048] 6. In the production of large-volume DNA nanospheres, since the temperature of the reaction system does not need to be changed, the time consumed by heating and cooling is reduced. The production time of the entire DNA nanosphere is close to the reaction time, less than 20 minutes. This is much lower than the actual time consumed by similar products on the market.

[0049] 7. The reagents have been optimized and integrated, and the components can be pre-mixed. There are only three reagent additions, including the termination reaction, and the steps are simple. Figure 3 Figure 4 shown.

[0050] One embodiment of the present application provides a method for rolling circle amplification, which is carried out under constant temperature conditions. Optionally, the constant temperature conditions are 40°C-80°C; optionally, the constant temperature conditions are 40°C-60°C; optionally, the constant temperature conditions are 40°C-45°C, exemplified by 40°C, 41°C, 42°C, 43°C, 44°C or 45°C.

[0051] Specifically include the following steps a~b:

[0052] Step a: The double-stranded DNA is mixed with a denaturant and then denatured to obtain a denatured system, wherein the 5' end of at least one strand of the double-stranded DNA is phosphorylated.

[0053] In a specific example, the denaturation is caused by a denaturant, which is a reagent that can denature double-stranded DNA at a fixed temperature between 0°C and 80°C.

[0054] In a specific example, the denaturant includes one or more of a strong base and formamide.

[0055] In a specific example, the denaturant is formamide. Optionally, the volume fraction of formamide in the denaturing system is 70%-90%.

[0056] In a specific example, the denaturant is a strong base, which includes NaOH and KOH.

[0057] In a specific example, the concentration of the strong base in the denaturing system is at the mol / L level.

[0058] In a specific example, the concentration of the strong base in the denaturing system is 0.05M-1.0M, optionally 0.09M-0.3M, optionally 0.25M-0.5M, and exemplified are 0.05M, 0.09M, 0.1M, 0.15M, 0.2M, 0.25M, 0.3M, 0.4M, 0.5M, 0.8M, and 1.0M.

[0059] In a specific example, the denaturation time does not exceed 5 minutes, exemplified by 2 minutes, 3 minutes, 4 minutes or 5 minutes.

[0060] Step b: After the DNA double-strand is denatured, reagents including a ring-forming sequence, a ligase and a polymerase are simultaneously introduced into the denaturation system to obtain a reaction system; in the reaction system, both ends of the denatured single-stranded DNA are simultaneously paired with the ring-forming sequence, the ligase connects the two ends of the single-stranded DNA to form a single-stranded DNA ring, and the polymerase performs rolling circle amplification using the ring-forming sequence as a primer and the single-stranded DNA ring as a template.

[0061] It is understood that the reagents introduced simultaneously also include polymerase buffer and dNTPs.

[0062] In a specific example, the reaction system includes a denatured DNA template, a polymerase, a polymerase buffer, a ligase, dNTPs, and a circularized fragment.

[0063] In existing one-step rolling circle amplification kits, denaturation of double-stranded libraries is usually achieved by changing temperature rather than denaturing agents. In these existing methods, ligation and rolling circle systems are performed at relatively low temperatures (such as 30°C), which is lower than the optimal hybridization temperature of common circular primers and single-stranded libraries (40°C for the MGI kit, for example). In this case, equipment that can perform precise temperature changes (PCR thermal cycler) is necessary. When using denaturants such as strong bases and formamide, it is necessary to consider additional neutralization steps and the effects of denaturants on subsequent reagents. Therefore, when a PCR instrument must be used, high-temperature denaturation is the most economical and efficient option, and it is almost the only option in current kits and existing technologies.

[0064] In one specific example, renaturation of double-stranded DNA is initiated by neutralization of a denaturing agent.

[0065] Neutralization of the denaturant can be achieved by consuming the denaturant through chemical reaction, enzyme digestion, antigen-antibody binding, affinity, etc. It can also be achieved by reducing the concentration of the denaturant through volume change so that it cannot function. It can also be a combination of the above effects.

[0066] In a specific example, a neutralizer is added to the reaction system to neutralize the reaction, and the neutralizer includes an acid, such as HCL.

[0067] In a specific example, the denaturant in the denaturing system of small volume is neutralized by the addition of a large volume of subsequent reagents. No additional renaturing agent needs to be added to renature. In a specific example, the total volume of reagents including looping sequence, ligase and polymerase introduced is 1-1000 times of the volume of the denaturing system, exemplified by 1 times, 2 times, 5 times, 8 times, 9 times, 10 times, 11 times, 12 times, 13 times, 14 times, 15 times, 16 times, 17 times, 18 times, 19 times, 20 times, 25 times, 30 times, 35 times, 40 times, 50 times, 80 times, 100 times, 120 times, 140 times, 160 times, 180 times, 200 times, 300 times, 400 times, 500 times, 600 times, 700 times, 800 times, 900 times, 1000 times, or the range composed of any two values. Optionally, the total volume of the reagents introduced including the looping sequence, the ligase and the polymerase is 1-500 times the volume of the denaturing system. Optionally, the total volume of the reagents introduced including the looping sequence, the ligase and the polymerase is 8-150 times the volume of the denaturing system. Optionally, the total volume of the reagents introduced including the looping sequence, the ligase and the polymerase is 8-30 times the volume of the denaturing system. Optionally, the total volume of the reagents introduced including the looping sequence, the ligase and the polymerase is 15-20 times the volume of the denaturing system.

[0068] In the present application, the ligase and polymerase used can work in the annealing environment of the circular primer, which includes temperature, buffer pH, and other reaction components, including but not limited to proteins, biomacromolecules, organic small molecules, inorganic salts and polymers.

[0069] In a specific example, the ligase is a thermostable ligase, the polymerase is a thermostable polymerase, and the reaction temperature suitable for the ligase and the polymerase is in the range of 20° C.-100° C. Optionally, the thermostable polymerase includes Phi 29 polymerase. Optionally, the ligase includes T4 DNA ligase.

[0070] In a specific example, the reaction time of the ligase and the polymerase is 10 min to 100 min. Optionally, the reaction time of the ligase and the polymerase is 10 min to 15 min, exemplified by 10 min, 11 min, 12 min, 13 min, 14 min or 15 min.

[0071] The present application selects a high temperature-adaptive reaction enzyme so that the entire reaction system can be kept at 40°C or higher, avoiding the situation where the temperature of the ring-forming primer hybridization is inconsistent with the reaction temperature and the temperature must be changed accurately. Under constant temperature reaction, the instrument can be simplified, and a PCR thermal cycler is not necessary, so the advantage of high temperature denaturation does not exist.

[0072] At the same time, the present application screened the reaction system of the enzyme, and by selecting a reaction buffer with a higher salt concentration and a lower pH environment, the neutralization step can be combined with the addition step of the ligation-rolling circle system, and the pH of the neutralized reaction system is close to neutral, and optionally, the pH value is 6.5-7.5, so that the enzyme has a relatively acceptable reaction activity in the neutralized reaction system. And by adjusting the denaturation system and the ligation-rolling circle system, including the volume, the order of adding samples, etc., the effect of the denaturant on the reactants can be reduced to negligible when the two systems are mixed.

[0073] In a specific example, the reaction system includes a denatured DNA template, a polymerase, a polymerase buffer, a ligase, dNTPs, and a circularized fragment, and optionally, a salt.

[0074] In a specific example, the working concentration of the denatured DNA template in the reaction system is 0.2 ng / μL-0.8 ng / μL. It is understandable that in other examples, the concentration of the denatured DNA template is not limited to the above, and can be adjusted according to actual needs.

[0075] In a specific example, the working concentrations of polymerase, ligase, and dNTPs in the reaction system can be adjusted according to actual needs.

[0076] In a specific example, the working concentration of the polymerase buffer in the reaction system is 0.8×-1.2×. It is understandable that in other examples, the concentration of the polymerase buffer is not limited to the above, and can be adjusted according to actual needs.

[0077] In a specific example, the working concentration of the cyclic fragment in the reaction system is 0.1 μM-0.2 μM. It is understandable that in other examples, the concentration of the cyclic fragment is not limited to the above, and can be adjusted according to actual needs.

[0078] In a specific example, the salt includes one or more of Tris-HCl, tetramethylammonium chloride, and Mg(CH3COO)2.

[0079] In a specific example, the working concentration of the salt in the reaction system is 0.005M-0.1M, and optional values ​​include but are not limited to 0.005M, 0.01M, 0.02M, 0.04M, 0.06M, 0.08M, and 0.1M.

[0080] In a specific example, the loop-forming sequence is paired with both ends of only one strand of the DNA double strand, and the 5' end of the strand is phosphorylated.

[0081] In a specific example, one or both of ATP and DTT are also introduced into the reaction system, and ATP participates in energy supply.

[0082] It should be noted that the circularization sequence, ligase, polymerase, polymerase reaction buffer, dNTP, ATP and / or DTT can be pre-mixed.

[0083] In a specific example, the volume of the reaction system is 1 μL-100 mL or higher, exemplified by 50 μL, 80 μL, 100 μL, 200 μL, 400 μL, 500 μL, 800 μL, 1 mL, 2 mL, 5 mL, 8 mL, 10 mL, 50 mL, 100 mL, or any range of the above two values.

[0084] In one specific example, a thermostatic heater or a PCR thermal cycler is used to maintain constant temperature conditions.

[0085] The rolling circle amplification method of the present application uses double-stranded DNA as a template, and double-stranded DNA after PCR purification or phosphorylation of a 5'phosphorylated PCR primer can be used for DNA nanoball preparation, without the need for single-stranded cyclization and purification steps, and without the need for complex instruments, which simplifies the equipment process for sample preparation and saves time and cost. The more advantageous part is that when making DNA nanoballs in large quantities, the situation of performing multiple batches of reactions in multiple PCR tubes is avoided. All the required DNA nanoballs can be prepared in one go through a large-volume reaction vessel, greatly improving production efficiency. And there is no quality difference in the product obtained from the commercial kit for making DNA nanoballs based on the existing method, and the reaction differences between PCR tubes and batches in the DNA nanoball production process are smaller.

[0086] An embodiment of the present application provides a method for preparing DNA nanospheres, and the DNA nanospheres are prepared by the above method.

[0087] When the concentration of the rolling circle amplification product reaches the required level, the reaction is terminated. The preparation method also includes terminating the obtained rolling circle amplification product with a terminator to obtain a DNA nanosphere.

[0088] The present invention creatively designs a rolling circle amplification system that can be performed in a constant temperature environment. The denaturation and rolling circle amplification of the system are all performed at the same constant temperature. This makes complex temperature control and variable temperature equipment such as PCR thermal cyclers unnecessary. At the same time, the process of reagent addition is simplified, with only three steps: denaturant, reaction reagent, and reaction terminator, reducing the interference of intermediate processes on DNB preparation; at the same time, by optimizing the volume of the denaturation system, the reaction reagent can directly renature the denatured library and start rolling circle amplification simultaneously. The above innovations also make it possible to produce DNBs using simple heating equipment; without the limitations of PCR thermal cyclers, large-scale DNB production does not need to be carried out in multiple PCR tubes, and large-volume containers can be used directly for reactions, avoiding batch differences in large-scale DNB production.

[0089] An embodiment of the present application provides a sequencing method, comprising the following steps:

[0090] Prepare DNA nanospheres according to the rolling circle amplification method; and

[0091] The DNA nanoballs are sequenced to obtain sequencing results.

[0092] One embodiment of the present application also provides a kit for preparing DNA nanoballs, which includes a denaturant, a ligase and a polymerase; optionally, it also includes a reaction buffer of the polymerase, dNTPs and ATP; optionally, the ligase, polymerase, reaction buffer of the polymerase, dNTPs and ATP are a premix; optionally, the denaturant includes one or more of a strong base and formamide.

[0093] The embodiments of the present application will be described in detail below in conjunction with examples. It should be understood that these examples are only used to illustrate the present application and are not intended to limit the scope of the present application. The experimental methods for which specific conditions are not specified in the following examples are preferably referred to the guidance provided in the present application, and can also be based on the experimental manual or normal conditions in this area, can also be based on the conditions recommended by the manufacturer, or refer to experimental methods known in the art.

[0094] In the following specific embodiments, the measured parameters of raw material components may have slight deviations within the range of weighing accuracy unless otherwise specified. For temperature and time parameters, acceptable deviations caused by instrument test accuracy or operation accuracy are allowed.

[0095] The loop-forming sequence used in the following examples is: GCCATGTCGTTCTGTGAGCCAAGG, SEQ ID NO: 1.

[0096] Example 1 Comparison of DNBs produced in this application, DNBs produced by the MGI one-step method, and DNBs produced by the MGI circular library

[0097] I DNB production

[0098] Ecoli gDNA samples were prepared into PCR libraries with phosphorylation modification at the 5' end for looping using MGIEasy Fast Enzyme Digestion Library Preparation Kit V2.0 (940-001193-00), UDB Primer Mix57, UDB Primer Mix58, and UDB Primer Mix59, respectively, and magnetic bead double selection was performed, with the main peak positions at 539, 545, and 522 (bp), respectively. The three PCR libraries were diluted with molecular grade water and quantified by Qubit™ dsDNA HS Assay to the same concentration (15.0ng / μL), and the libraries were numbered as sample 57, sample 58, and sample 59 according to the UDB Primer Mix used.

[0099] Sample 57 was circularized and purified using the MGIEasy Dual Barcode Circularization Kit (1000020570) according to the instructions, and then DNB was prepared using the DNB preparation reagent in the MGISEQ-2000RS High-throughput Rapid Sequencing Reagent Set (FCL PE100). The quantitative concentration of the sample was 12.7 ng / μL using the Qubit™ ssDNA Assay, and the sample was numbered DNB 57.

[0100] Sample 58 was prepared using the DNBSEQ One-Step DNB Preparation Kit V2.0 (OS-DB) (940-000036-00), and the product was quantified by Qubit™ ssDNA Assay with a concentration of 13.2 ng / μL, numbered DNB 58.

[0101] Sample 59 was processed by the method of this application as follows:

[0102] Take 45ng of PCR product, add 1μL 1M NaOH, and place it in a PCR tube. Keep the temperature at 40℃ in a PCR thermal cycler for 3min. Then mix 2μL phi29-XT polymerase (NEB, M0572SVIAL), 1μL Hi-T4™ DNALigase (NEB, M2622S), 8μL Deoxynucleotide (dNTP) Solution Mix (NEB, N0447SVIAL), 16μL 5×phi29-XT Reaction Buffer, 8μL ATP (NEB, P0756S), 1μL 0.5M DTT (A39255), 10μL 1μmol circular primer solution, 1.5μL 0.5M Tris-HCl (Sigma, T6666), and 28.5μL molecular grade water. Then add it to the PCR tube at one time and heat it for 15min with the lid closed. Then, 20 μL 0.1 M EDTA (Invitrogen, AM9912) was added to terminate the reaction. The product was quantified by Qubit™ ssDNA Assay with a concentration of 17.4 ng / μL and numbered DNB 59.

[0103] DNB 58 and DNB 59 were diluted as close to the concentration of DNB 57 as possible using DNB loading buffer I in the MGISEQ-2000RS High-throughput Rapid Sequencing Reagent Set (FCL PE100).

[0104] The total time of the whole process including the instrument was calculated, and DNB 57 took about 2 hours, DNB 58 took 35 minutes, and DNB 59 took 20 minutes. The method of preparing DNB by the present application takes significantly less time than other methods.

[0105] II. Loading of DNB

[0106] Take 50 μL of each of DNB 57, diluted DNB 58, and diluted DNB 59, add 16 μL of DNB loading buffer II and 0.5 μL of DNB loading buffer II (LC), and mix them well. Load DNBs onto the chip through MGIDL-200H. L1 is loaded with DNB 57, L2 is loaded with DNB 58, L3 is loaded with DNB 59, and L4 is loaded with a 1:1:1 mixture of DNB 57, DNB 58, and DNB 59.

[0107] III Sequencing

[0108] MGISEQ-2000RS was used to perform PE100 sequencing and split the Index. The sequencing results are shown in Table 1 below.

[0109] Table 1

[0110]

[0111] As can be seen in Table 1, the sequencing quality of DNBs obtained by the one-step method of the present application is close to that of DNBs obtained by the MGI library construction sequencing kit, and is higher than that of DNBs obtained by the MGI one-step kit. After the DNBs were mixed, the detection ratios of DNBs from the three sources were close, indicating that the generation efficiency of DNBs obtained by the present application is also close to that of the MGI kit method, and the quality and quantity of DNBs are consistent.

[0112] Example 2 Medium-scale production of DNB by the method of the present application

[0113] I DNB production

[0114] With 1.0 mL of DNB as the target, sample 58 was prepared using the DNBSEQ One-Step DNB Preparation Kit V2.0 (OS-DB) (940-000036-00) and four tubes of products were obtained using an RCP thermal cycler. The products were quantified by Qubit™ ssDNA Assay and their concentrations were 13.7 ng / μL, 15.1 ng / μL, 11.9 ng / μL, and 14.2 ng / μL, respectively, and were numbered DNB 58-1, DNB 58-2, DNB58-3, and DNB 58-4.

[0115] With 1.0 mL of DNB as the target, sample 59 was processed using the method of the present application as follows:

[0116] Add 450 ng of PCR product to a 2.0 mL centrifuge tube, add 10 μL of 1 M NaOH, mix well, place in a constant temperature water bath set at 42°C, and let stand for 3 minutes. Also preheat molecular grade water in a constant temperature water bath. Then, 20 μL phi29-XT polymerase (NEB, M0572SVIAL), 10 μL Hi-T4™ DNA Ligase (NEB, M2622S), 80 μL Deoxynucleotide (dNTP) Solution Mix (NEB, N0447SVIAL), 160 μL 5×phi29-XT Reaction Buffer, 80 μL ATP (NEB, P0756S), 10 μL 0.5M DTT (A39255), 100 μL 1 μmol / L circular primer solution, 15 μL 0.5M Tris-HCl (Sigma, T6666) were mixed with 285 μL preheated molecular grade water. Then, they were added to the PCR tube at one time, pipetted three times to mix thoroughly, and the centrifuge tube was closed and heated for 15 minutes. Then, 200 μL of 0.1M EDTA (Invitrogen, AM9912) was added to terminate the reaction, and 1.0 mL of product was obtained. 102 μL of the product was successively drawn and added to four PCR tubes, and the concentrations were quantified by Qubit™ ssDNA Assay to be 18.2 ng / μL, 18.4 ng / μL, 18.0 ng / μL, and 18.1 ng / μL, and they were numbered DNB 59-1, DNB 59-2, DNB 59-3, and DNB 59-4, respectively.

[0117] II DNB loading and sequencing

[0118] DNB 58-1, DNB 58-2, DNB 58-3, and DNB58-4 were loaded onto L1-L4 of chip 1 by MGI DL-200H. DNB 59-1, DNB 59-2, DNB 59-3, and DNB 59-4 were loaded onto L1-L4 of chip 2. MGISEQ2000 was then used to perform PE100 sequencing in dual-carrier mode. The results are shown in Table 2 below.

[0119] Table 2

[0120]

[0121] As can be seen in Table 2, the DNB produced by the present application can simply amplify the reaction volume. Compared with the existing one-step method of amplification through multiple tubes, the steps are simpler, and the products show lower cv values ​​(Coefficient of variation) from the three dimensions of DNB concentration, sequencing Q30 and CleanReads, that is, higher uniformity.

[0122] Example 3 Ultra-large volume production of DNB by the method of the present application

[0123] I DNB production.

[0124] DNB was produced with a target volume of 10 mL.

[0125] Take undiluted sample 59, dilute it with molecular grade water, and the concentration is quantified by Qubit™ dsDNA HSAssay to 87.1 ng / μL, marked as sample 59C. Use a 1.5 mL centrifuge tube to mix 51.6 μL of sample 59C with 5.4 μL 1M KOH, and place it in a 42°C water bath for denaturation reaction, and time it for 5 minutes.

[0126] Add stirring magnetic beads, 200μL phi29-XT polymerase (NEB, M0572SVIAL), 100μL Hi-T4™ DNA Ligase (NEB, M2622S), 800μL Deoxynucleotide (dNTP) Solution Mix (NEB, N0447SVIAL), 1600μL 5×phi29-XT Reaction Buffer, 800μL ATP (NEB, P0756S), 100μL 0.5M DTT (A39255), 1mL 1μmol / L circular primer solution, 3337.6μL molecular grade water to a 40mL round-bottom flask centrifuge tube that has been thoroughly cleaned and sterilized by high temperature baking, mix, and stir the magnetic beads at 500RPM. After the 5-minute timing is over, add 5.4μL 1M HCl to the 1.5mL centrifuge tube of the denaturation reaction to neutralize the denaturation. Then use a 100μL pipette to mix the reaction solution and then quickly add it to the round-bottom flask all at once. After 15s, reduce the stirring speed of the magnetic beads to 50RPM and make sure that the water bath covers the reaction liquid surface.

[0127] The flask was sealed with a stopper equipped with an air pressure balance device, and heated with low-speed stirring for 15 min. Then, 2 mL of 0.1 M EDTA (Invitrogen, AM9912) was added to terminate the reaction.

[0128] II DNB loading and sequencing

[0129] 100 μL of the reaction product was taken from the upper, middle, lower and random positions of the flask using a widened pipette tip and named DNB-59C-U, DNB-59C-M, DNB-59C-L and DNB-59C-R. The four products were quantified using Qubit™ ssDNA Assay and the concentrations were as shown in the following table.

[0130] DNB-59C-U, DNB-59C-M, DNB-59C-L, and DNB-59C-R were loaded onto L1-L4 of chip 1 by MGI DL-200H, and then PE100 sequencing was performed using MGISEQ 2000 in dual-carrier mode. The results are shown in Table 3.

[0131] Table 3

[0132]

[0133] It can be seen that the DNB prepared by the present invention has almost the same steps even on a scale of 10 mL, and the product shows lower cv values ​​in terms of DNB concentration, sequencing Q30 and CleanReads, showing high uniformity.

[0134] Example 4 Various sample tests

[0135] Bronchoalveolar lavage fluid and fluid-derived samples.

[0136] I. Sample processing

[0137] Bronchoalveolar lavage fluid and sputum samples were processed using the MGIEasy Microbial DNA Extraction Kit (1000027955).

[0138] The processing steps are as follows:

[0139] (1) First, add 500 μL of zirconium oxide beads to a 2.0 mL centrifuge tube, then take 700 μL of sample and add it. Place the tube in a cell wall breaker at 5000 rpm for 1 min. Centrifuge at 8000 rpm for 1 min. Take 300 μL of the supernatant sample obtained after cell wall breaker and place it in a 1.5 mL centrifuge tube to continue the operation.

[0140] (2) Add 20 μL of proteinase K solution and 300 μL of Buffer LB to the treated sample, mix well, and place on a constant temperature mixer at 1200 rpm and incubate at 65°C for 15 min.

[0141] (3) Add 350 μL of isopropanol and mix well.

[0142] (4) Add 20 μL of magnetic beads, mix well and equilibrate for 3 min, then discard the supernatant on the magnetic rack.

[0143] (5) Add 500 μL of BW1 washing solution, equilibrate at room temperature for 1 min, then remove the supernatant using a magnetic rack and repeat once.

[0144] (6) Dry the remaining magnetic beads for 5 min. Add 80 μL of elution buffer and incubate at 56°C for 5 min at 1000 rpm on a mixer.

[0145] (7) Separate the supernatant using a magnetic rack, aspirate and save. Label them as Lib1 and Lib2 respectively.

[0146] The corresponding 5' phosphorylation libraries were prepared by MGIEasy Fast Enzyme Digestion Library Preparation Kit V2.0 (940-001193-00), and Lib1 and Lib2 were diluted to 22.4 ng / μL and 26.7 ng / μL, respectively. 45 ng of diluted Lib1 and Lib2 were taken in different 1.5 mL centrifuge tubes. 6 μL of formamide was added to each of the two tubes, and placed in a constant temperature water bath at 45°C for 5 minutes. During this period, two identical reaction solutions were prepared, each containing the following components: 2μL phi29-XT polymerase (NEB, M0572SVIAL), 1μL Hi-T4™ DNA Ligase (NEB, M2622S), 2μL Deoxynucleotide (dNTP) Solution Mix (NEB, N0447SVIAL), 16μL 5×phi29-XT Reaction Buffer, 8μL ATP (NEB, P0756S), 1μL 0.5M DTT (Thermo, A39255), 1μL 1M Mg(CH3COO)2(aq) (Sigma, 63052), and 1μL 5M Tetramethylammonium chloride (Sigma, T3411). After sufficient mixing, add 38 μL of preheated molecular grade water and 10 μL of 1 μmol / L circular primer to each, and then immediately add to the 1.5 mL centrifuge tubes containing Lib1 and Lib2. Mix by pipetting and start timing. After 12 minutes, add 20 μL of 0.1M EDTA (Invitrogen, AM9912) to each of the two centrifuge tubes to terminate the reaction, and obtain DNB-Lib1 and DNB-Lib2 with concentrations of 27.3 ng / μL and 31.5 ng / μL, respectively. SE100 sequencing was performed using MGISEQ 2000, and the results are shown in Table 4:

[0147] Table 4

[0148]

[0149] It can be seen that the amount of data generated and the data quality are also within the normal range.

[0150] The technical features of the above-described embodiments may be arbitrarily combined. To make the description concise, not all possible combinations of the technical features in the above-described embodiments are described. However, as long as there is no contradiction in the combination of these technical features, they should be considered to be within the scope of this specification.

[0151] The above-mentioned embodiments only express several implementation methods of the present application, and the descriptions thereof are relatively specific and detailed, but they cannot be understood as limiting the scope of the invention patent. It should be pointed out that, for a person of ordinary skill in the art, several variations and improvements can be made without departing from the concept of the present application, and these all belong to the protection scope of the present application. Therefore, the protection scope of the patent of the present application shall be subject to the attached claims, and the description may be used to interpret the content of the claims.

Claims

1. Rolling circle amplification method, It is characterized in that The method is carried out under constant temperature conditions and comprises the following steps: The double-stranded DNA is mixed with a denaturant and then denatured to prepare a denaturation system, wherein the 5' end of at least one strand of the double-stranded DNA is phosphorylated; After the DNA double strands are denatured, reagents including a circular fragment, a ligase and a polymerase are simultaneously introduced into the denaturation system to prepare a reaction system; in the reaction system, both ends of the denatured single-stranded DNA are simultaneously paired with the circular fragment, the ligase connects the two ends of the single-stranded DNA to form a single-stranded DNA ring, and the polymerase performs rolling circle amplification using the circular fragment as a primer and the single-stranded DNA ring as a template.

2. The method according to claim 1, It is characterized in that The total volume of the reagents introduced, including the circular fragment, the ligase and the polymerase, is 1-1000 times the volume of the denaturing system; Optionally, the total volume of the introduced reagents including the circularized fragment, the ligase and the polymerase is 1-500 times the volume of the denaturation system; Optionally, the total volume of the reagents introduced including the circularized fragment, the ligase and the polymerase is 80-150 times the volume of the denaturation system; Optionally, the total volume of the introduced reagents including the circularized fragment, the ligase and the polymerase is 15-20 times the volume of the denaturation system.

3. The method according to claim 1 or 2, It is characterized in that The denaturant includes one or more of a strong base and formamide; Optionally, the denaturant is a strong base; further optionally, the strong base includes NaOH and KOH; Optionally, the concentration of the strong base in the denaturing system is at the mol / L level.

4. The method according to claim 1 or 2, It is characterized in that The denaturation time should not exceed 5 minutes.

5. The method according to claim 1 or 2, It is characterized in that The constant temperature condition is 40°C-80°C; Optionally, the constant temperature condition is 40°C-60°C; Optionally, the constant temperature condition is 40°C-45°C.

6. The method according to claim 1 or 2, It is characterized in that The ligase is a thermostable ligase, the polymerase is a thermostable polymerase, and the suitable reaction temperature of the ligase and the polymerase is in the range of 20°C-100°C.

7. The method according to claim 1 or 2, It is characterized in that The reaction time of the ligase and the polymerase is 10 min-100 min; Optionally, the reaction time of the ligase and the polymerase is 10 min-15 min.

8. The method according to claim 1 or 2, It is characterized in that The circularized fragment is paired with both ends of only one strand of the DNA double strand simultaneously, and the 5' end of the paired strand is phosphorylated.

9. The method according to claim 1 or 2, It is characterized in that One or more of ATP, salt and neutralizing agent are also introduced into the reaction system; Optionally, the salt includes Tris-HCl, tetramethylammonium chloride and Mg(CH 3 COO 2 One or more of; Optionally, the neutralizing agent comprises an acid.

10. The method according to claim 1 or 2, It is characterized in that The volume of the reaction system is 1 μL-100 mL; Optionally, the volume of the reaction system is 80 μL-10 mL.

11. The method according to claim 1 or 2, It is characterized in that Use a thermostatic heater or a PCR thermal cycler to maintain constant temperature conditions.

12. A method for preparing DNA nanospheres, It is characterized in that The method comprises preparing DNA nanospheres by using any one of claims 1 to 11; Optionally, the preparation method further comprises terminating the amplification reaction with a terminator to obtain DNA nanospheres.

13. A sequencing method, It is characterized in that The steps include: Preparation of DNA nanospheres according to the rolling circle amplification method according to any one of claims 1 to 11; and The DNA nanoballs are sequenced to obtain sequencing results.